USP22 and breast carcinoma: Finally, we examined ERBB2 levels with and without USP22 depletion in two HER2-positive human breast cancer cell lines, SKBR3 and HCC1954, and again saw no impact on ERBB2 protein levels upon USP22 loss (Fig 5E).